111 related articles for article (PubMed ID: 8815641)
21. [Combined use of local and systemic radiomodifiers as a new modality of cervical carcinoma therapy].
Neklasova NIu; Zharinov GM; Vinokurov VL; Skrynditsa GM
Vopr Onkol; 2006; 52(5):560-4. PubMed ID: 17168367
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of diffused laryngeal and pharyngeal cancer with preoperative radiotherapy in combination with radiation-modifying agents].
Andreev VG; Romanko IuS
Vestn Otorinolaringol; 1995; (4):13-6. PubMed ID: 7676553
[TBL] [Abstract][Full Text] [Related]
23. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
24. Olfactory neuroblastoma: a case report and review of the literature.
Ghaffar S; Salahuddin I
Ear Nose Throat J; 2005 Mar; 84(3):150-2. PubMed ID: 15871582
[TBL] [Abstract][Full Text] [Related]
25. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.
Dirix P; Nuyts S; Vanstraelen B; Nulens A; Hermans R; Jorissen M; Vander Poorten V; Van den Bogaert W
Radiother Oncol; 2007 Dec; 85(3):385-91. PubMed ID: 17963908
[TBL] [Abstract][Full Text] [Related]
26. [Multivariate analysis of prognosis of patients with stage IE non-Hodgkin's lymphomas of the nasal cavity].
Hu W; Chen M; Luo F
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):240-3. PubMed ID: 11783097
[TBL] [Abstract][Full Text] [Related]
27. [Malignant melanoma of nasal cavity: report of 24 cases].
Chen M; Lin Z; Tang X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):246-7. PubMed ID: 8745469
[TBL] [Abstract][Full Text] [Related]
28. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
30. Malignancies of the nasal cavity and paranasal sinuses: long-term outcome with conventional or three-dimensional conformal radiotherapy.
Dirix P; Nuyts S; Geussens Y; Jorissen M; Vander Poorten V; Fossion E; Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1042-50. PubMed ID: 17570610
[TBL] [Abstract][Full Text] [Related]
31. Therapy and survival in male breast carcinoma: A retrospective analysis of 50 cases.
Margaria E; Chiusa L; Ferrari L; Dal Canton O; Pich A
Oncol Rep; 2000; 7(5):1035-9. PubMed ID: 10948335
[TBL] [Abstract][Full Text] [Related]
32. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma of the nasal cavity and paranasal sinuses.
Mendenhall WM; Amdur RJ; Morris CG; Kirwan J; Malyapa RS; Vaysberg M; Werning JW; Mendenhall NP
Laryngoscope; 2009 May; 119(5):899-906. PubMed ID: 19358246
[TBL] [Abstract][Full Text] [Related]
34. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
[TBL] [Abstract][Full Text] [Related]
35. Squamous cell carcinoma of the anterior nasal cavity: a dual institution review.
Fornelli RA; Fedok FG; Wilson EP; Rodman SM
Otolaryngol Head Neck Surg; 2000 Sep; 123(3):207-10. PubMed ID: 10964292
[TBL] [Abstract][Full Text] [Related]
36. Esthesioneuroblastoma: continued follow-up of a single institution's experience.
Loy AH; Reibel JF; Read PW; Thomas CY; Newman SA; Jane JA; Levine PA
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):134-8. PubMed ID: 16490869
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in maxillary sinus and nasal cavity carcinoma.
Carrillo JF; Güemes A; Ramírez-Ortega MC; Oñate-Ocaña LF
Eur J Surg Oncol; 2005 Dec; 31(10):1206-12. PubMed ID: 15923101
[TBL] [Abstract][Full Text] [Related]
38. [Integral radiation-modulating therapy of malignant tumors of the nasal cavity and paranasal sinuses].
Bykov VL
Vestn Otorinolaringol; 1987; (6):47-50. PubMed ID: 3438976
[No Abstract] [Full Text] [Related]
39. Paranasal sinus tumors: Peter MacCallum Cancer Institute experience.
Porceddu S; Martin J; Shanker G; Weih L; Russell C; Rischin D; Corry J; Peters L
Head Neck; 2004 Apr; 26(4):322-30. PubMed ID: 15054735
[TBL] [Abstract][Full Text] [Related]
40. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
